SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,472.94 -183.15
( -0.24%)

Global Indices

Nasdaq

53,487.87 -110.53
(-0.21%)

Dow Jones

7,697.38 -0.90
(-0.01%)

Hang Seng

66,269.23 412.80
(0.63%)

Nikkei 225

10,888.36 2.20
(0.02%)

Forex

USD-INR

95.70 0.06
(0.07%)

EUR-INR

111.67 0.01
(0.01%)

GBP-INR

130.50 0.05
(0.04%)

JPY-INR

0.60 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Timex Group India Ltd

Industry : Miscellaneous

BSE Code

ISIN Demat

Book Value()

500414

INE064A01026

7.4675582

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

TIMEX

71.27

6360.35

EPS(TTM)

Face Value()

Div & Yield %

8.84

Back

Natco Pharma announces conclusion of USFDA inspection of its Visakhapatnam unit

Aug 22,2026

Natco Pharma announced conclusion of US FDA Inspection at its Visakhapatnam, Andhra Pradesh, Finished Dosage Formulations (FDF) Unit. The inspection was conducted from 17 August to 21 August 2026.

Upon conclusion of the inspection, the Company has been issued a Form 483 with 4 (Four) observations.

77,472.94 -183.15 ( -0.24%)

53,487.87 -110.53 (-0.21%)

7,697.38 -0.90 (-0.01%)

66,269.23 412.80 (0.63%)

10,888.36 2.20 (0.02%)

95.70 0.06 (0.07%)

111.67 0.01 (0.01%)

130.50 0.05 (0.04%)

0.60 0.00 (0.01%)